PAVmed Subsidiary, Lucid Diagnostics, Files Registration Statement for Proposed Initial Public OfferingBusiness Wire • 09/23/21
PAVmed Subsidiary Veris Health Joins Microsoft for Startups Global Program and Engages Loka as Software Development PartnerBusiness Wire • 09/21/21
PAVmed Inc. (PAVM) CEO Lishan Aklog on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/13/21
PAVmed Provides Business Update and Preliminary Second Quarter 2021 Financial ResultsBusiness Wire • 08/12/21
Global Industry Executive Aster Angagaw Joins PAVmed Subsidiary Lucid Diagnostics' Board of DirectorsBusiness Wire • 08/03/21
CORRECTING and REPLACING PAVmed to Hold Business Update Conference Call on August 12, 2021Business Wire • 08/02/21
Stanley Lapidus, Founder and Former Chairman & CEO of Exact Sciences, Joins PAVmed Subsidiary Lucid Diagnostics as Vice Chairman of its Board of DirectorsBusiness Wire • 07/28/21
PAVmed Subsidiary Lucid Diagnostics Launches Strategic Partnership with Direct-to-Consumer Telemedicine Company UpScriptHealthBusiness Wire • 07/22/21
Tim Baxter, Former CEO of Samsung Electronics North America and Global Technology Industry Leader, Joins PAVmed Board of DirectorsGlobeNewsWire • 06/14/21
PAVmed Subsidiary Lucid Diagnostics Completes European CE Mark Certification of its EsoGuard Esophageal DNA TestGlobeNewsWire • 06/10/21
PAVmed Subsidiary Lucid Diagnostics Receives CE Mark Certification for its EsoCheck® Esophageal Cell Collection DeviceGlobeNewsWire • 05/26/21